Two Clinical Researchers from University Hospitals Coventry and Warwickshire NHS Trust (UHCW) Shortlisted for Prestigious National Award

Christopher Poole, Professor of Medical Oncology and Dr Jane Worlding, a Consultant Clinical Oncologist at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust, have been shortlisted in the National Institute of Health Research (NIHR) Industry Principal Investigator Awards.

Professor Poole was shortlisted for regularly exceeding recruitment targets for clinical studies run by UHCW, including a study into a drug combination for ovarian cancer, and Dr Worlding was shortlisted for successfully delivering a study into a therapy for patients with bone cancer.

Professor Poole and Dr Worlding are among nine clinical researchers in the region to be shortlisted.

Professor Christopher Poole said:
“I was delighted and surprised to be shortlisted for this award. It’s important that we are able to offer patients the opportunity to participate in clinical studies, and the only way that we are able to do this is through teamwork. And of course, it’s only through clinical studies that we are able to develop better treatments for the future.”

Dr Jane Worlding added:
“I’ was thrilled to hear that my study had been shortlisted. The study for metastatic prostate cancer patients with a novel radioisotope added to a standard treatment is very exciting. This treatment may eventually be valuable to a large number of patients whose cancer has travelled to their bones.”

The results will be announced at an awards ceremony on 19 February in London.


The Clinical Research Network is part of the National Institute for Health Research.
We are a coordinated national network that enables and embeds high quality research as core business across health and social care to make people and the NHS better. We do this by:
• Ensuring that as many people as possible across England have the opportunity to participate in research;
• Providing researchers with the practical support they need to make clinical research studies happen in the NHS;
• Ensuring the efficient and effective delivery of high quality clinical research across the health community;
• Attracting national and international clinical research investment; and
• Providing a coordinated response to national research priorities

About the NIHR
The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has:

• increased the volume of applied health research for the benefit of patients and the public
• driven faster translation of basic science discoveries into tangible benefits for patients and the economy
• developed and supported the people who conduct and contribute to applied health research.

The NIHR plays a key role in the Government’s strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence and systems represent the most integrated health research system in the world. For further information, visit the NIHR website (